In 2023, Christopher Ryan, Ph.D. earned $1.23M in total compensation at Gevo, including $421.51K salary, $423.09K bonus and $381.83K in stock. Most recently acquired 10,000 shares in Sep 2024. Currently holds stock worth $3.42M. Has led Gevo for over 13 years.
Compensation History
Annual executive compensation data for Christopher Ryan, Ph.D., including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$1.23M
Salary
$421.51K
Bonus
$423.09K
Other
$0.00
Salary
$421.51KBoard Justification
The compensation philosophy focuses on aligning executive compensation with company performance and long-term shareholder value, using a mix of cash and equity incentives to attract and retain top talent.
Bonus
$423.09KBoard Justification
The bonus is based on the achievement of certain business goals set by the Board on an annual basis, including a Special Net-Zero 1 Bonus for significant progress made towards achieving financial close for the Net-Zero 1 project.
Other Compensation
$0.00Board Justification
No additional compensation reported for 2023.
Restricted Stock
Board Justification
The stock awards that vested in 2023 were granted in prior years and are based on the achievement of performance metrics and continued service with the company.
Performance Metrics
The performance metrics include achieving specific business goals set by the Board, which are tied to the company's operational and financial objectives.
Christopher Ryan, Ph.D.
CEO of Gevo
Sector of Economy
Basic Materials
CEO of Gevo for
13 years 2 months (Sep 2012 - Present)
Previous Experience
Unknown
Holdings
Track Christopher Ryan, Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$1.16M
$1.16M
498,668 GEVO shares
What if they kept their stock?
If Christopher Ryan, Ph.D. didn't sell their stock, today they would have:
Extra GEVO498,668 shares worth $1.11M.
This is -3.74% and $43.24K less than what they got when they sold the stock.
Insider Trading
Christopher Ryan, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
10,000 shares
GEVO
Sep 1, 2024
Received
$63.63K
GEVO at $0.76/share
Aug 22, 2024
Sale
$23.58K
GEVO at $0.51/share
Aug 6, 2024
Sale
$23.48K
GEVO at $0.59/share
Jul 31, 2024
Sale
550,000 shares
GEVO
May 22, 2024
Received
$115.62K
GEVO at $1.38/share
Aug 23, 2023
Sale
266,220 shares
GEVO
Aug 3, 2023
Received
$60.27K
GEVO at $1.65/share
Jul 28, 2023
Sale
$207.85K
GEVO at $3.08/share
Aug 22, 2022
Sale
234,711 shares
GEVO
Jul 26, 2022
Received
Rivals
Compare Christopher Ryan, Ph.D. with competitor CEOs and industry peers.